Multicenter RCT Abstract Highlighting Spiracur’s SNaP System Wins Highest Scoring Award at Symposium for Advanced Wound Care

SUNNYVALE, CA--(Marketwire - October 04, 2011) - The Symposium on Advanced Wound Care (SAWC) has awarded David G. Armstrong, DPM, M.D., Ph.D., et al., the highest scoring abstract in the clinical research category for their poster entitled, "Comparative Effectiveness of Mechanically and Electrically Powered Negative Pressure Wound Therapy (NPWT) Devices: A Multicenter Randomized Controlled Trial." Addressing a major healthcare concern, the poster highlights the treatment options of chronic wounds, and includes analysis in support of the safety of NPWT, the delivery of negative pressure for wound healing.

This winning abstract will be presented at the upcoming SAWC Fall 2011, October 13-15, in Las Vegas. The competition was judged by the North American Center for Continuing Medical Education, LLC (NACCME).

"A total of 150 abstracts were accepted as posters based on a blind, peer-review by judges who are experts in the field," said Tiffney D. Oliver, director of educational services for NACCME. "Of those, 28 were designated as clinical research. All abstracts were reviewed based on specific criteria for the category in which it was placed, including clear objectives, importance and interest, design, significance of findings, relevance of outcomes and appropriate statistical measures. The highest scoring clinical research award represented the clinical research abstract that received the highest overall score within its category by our judges."

Dr. Armstrong's winning poster highlights a 17-center randomized-controlled trial (RCT), which enrolled 132 subjects with chronic, non-infected, non-ischemic, non-plantar lower extremity diabetic and venous wounds. The study was designed to compare the ultraportable mechanically powered SNaP® Wound Care System from Spiracur Inc. to the electrically powered Vacuum-Assisted Closure (V.A.C.®) Therapy System from Kinetic Concepts, Inc. Data includes promising analysis supporting the efficacy and safety of the SNaP System in the treatment of chronic lower extremity wounds. Dr. Armstrong, principal investigator of the study, along with William A. Marston, M.D., Alexander M. Reyzelman, DPM and Robert S. Kirsner, M.D., Ph.D., have completed the study and submitted the final manuscript for peer-review.

According to Dr. Armstrong, who is Professor of Surgery and Director of the Southern Arizona Limb Salvage Alliance (SALSA) at the University of Arizona, "The results from this study are rather encouraging. They lend further evidence to the body of literature surrounding NPWT, which can only help us further in our efforts to heal wounds and prolong the quality and quantity of life for our patients."

The SNaP System (Smart Negative Pressure®) is a non-powered device that is completely silent and lightweight, weighing only 2.2 ounces, and easily fits under a patient's clothing during treatment.

"We are thrilled that Dr. Armstrong's poster is recognized as the highest scoring abstract in the clinical research category by wound care experts at one of the largest, and most esteemed conferences for wound care specialists and clinicians in the nation," said Gary Restani, president and CEO for Spiracur Inc.

About Spiracur Inc.
Spiracur Inc., headquartered in Sunnyvale, Calif., is a privately held medical device company focused on the development of innovative wound healing technologies. Spiracur was founded out of the Stanford Biodesign Innovation Program in 2007. Its first product, the SNaP Wound Care System, is the result of patient and clinician feedback that current negative pressure wound therapies were too cumbersome. The SNaP Wound Care System was cleared by the U.S. Food & Drug Administration (FDA) in August 2009 in a new therapy category defined as "non-powered" NPWT devices, and the company obtained CE Mark for the device in December 2010. For more information, please visit http://www.spiracur.com.

Spiracur, Spiracur logo, SNaP, SNaP & Design and Smart negative Pressure are registered trademarks of Spiracur Inc.


Media Contact:
Amy Cook
For Spiracur
925.552.7893
Email Contact

Investor Contact:
For Spiracur
Steve Van Dick
408.701.5300
Email Contact

MORE ON THIS TOPIC